Bixiye
P23-21 2021 Renewal Changes Summary for Blue Plus Referral Health Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1911 - 1920 ee natiijooyinka 3563
Bixiye
QP37-21 New Clinical Survey for Psychological and Neuropsychological Testing
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP39-21 Claims Status Listing Tool
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP34-21 Is Authorization Required (IAR) Tool for Outpatient Authorization on Availity Portal
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP36-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: ZokinvyTM (lonafarnib) PA with QL
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP35-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Verquvo® (vericiguat) PA with QL
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP38-21 Commercial and MHCP Pharmacy Benefit Exclusion for Abecma®
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP33-21 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) Criteria: Winlevi®
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021